The purpose of this legislation is to improve access to opioid overdose reversal drugs by providing no-cost coverage for these medications under Medicare, Medicaid, and TRICARE. The aim is to help prevent opioid overdoses by ensuring that individuals at risk receive these life-saving drugs when they leave hospitals or emergency care settings. Key provisions of the law include the requirement that Medicare and Medicaid cover preventive opioid overdose reversal drugs without any cost-sharing for patients.